Item(by='jimmydorry', descendants=None, kids=[25742200], score=None, time=1610424424, title=None, item_type='comment', url=None, parent=25742096, text='The pfizer vaccine looks to be sitting closer to 30%[1] than 95% based on the parts of their trial data they are choosing to release.<p>&gt;With 20 times more suspected than confirmed cases, this category of disease cannot be ignored simply because there was no positive PCR test result. Indeed this makes it all the more urgent to understand. A rough estimate of vaccine efficacy against developing covid-19 symptoms, with or without a positive PCR test result, would be a relative risk reduction of 19% (see footnote)â€”far below the 50% effectiveness threshold for authorization set by regulators.<p>[1] <a href="https:&#x2F;&#x2F;blogs.bmj.com&#x2F;bmj&#x2F;2021&#x2F;01&#x2F;04&#x2F;peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data&#x2F;" rel="nofollow">https:&#x2F;&#x2F;blogs.bmj.com&#x2F;bmj&#x2F;2021&#x2F;01&#x2F;04&#x2F;peter-doshi-pfizer-and-...</a>')